Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 40,136 | 35,780 | 30,830 | 26,841 | 29,835 |
| Cost of Goods | 13,670 | 13,189 | 11,881 | 11,118 | 11,144 |
| Gross Profit | 26,466 | 22,591 | 18,949 | 15,723 | 18,691 |
| Operating Expenses | 21,549 | 18,553 | 13,242 | 10,413 | 10,284 |
| Operating Income | 5,587 | 4,227 | 6,587 | 5,428 | 8,551 |
| Other Income | -74 | 499 | 2,101 | 2,101 | 1,241 |
| Pre-tax Income | 5,512 | 4,725 | 8,688 | 7,528 | 9,792 |
| Income Tax | 1,825 | 1,096 | 2,653 | 2,924 | 3,899 |
| Net Income Continuous | 3,688 | 3,629 | 6,035 | 4,604 | 5,893 |
| Net Income | $3,688 | $3,629 | $6,035 | $4,604 | $5,893 |
| EPS Basic Total Ops | 0.32 | 0.32 | 0.55 | 0.43 | 0.57 |
| EPS Basic Continuous Ops | 0.32 | 0.32 | 0.55 | 0.43 | 0.57 |
| EPS Diluted Total Ops | 0.32 | 0.32 | 0.53 | 0.41 | 0.52 |
| EPS Diluted Continuous Ops | 0.32 | 0.32 | 0.53 | 0.41 | 0.52 |
| EBITDA(a) | $6,880 | $5,662 | $7,406 | $5,812 | $9,010 |